NERP-4-Deleted VGF Impairs β-Cell Granulogenesis and Insulin Secretion

Area of Science:

• Endocrinology and Metabolism
• Cell Biology
• Molecular Biology

Background:

• Neuroendocrine regulatory peptide-4 (NERP-4) is derived from the VGF protein and modulates the SNAT2 amino acid transporter on pancreatic beta cells.
• NERP-4 is known to promote insulin secretion and beta cell survival.

Purpose of the Study:

• To investigate the functional impact of NERP-4 deletion from VGF on pancreatic beta cell function and maintenance.
• To explore the role of NERP-4 in insulin granule formation and secretion.
• To assess the relevance of NERP-4 in the context of type 2 diabetes mellitus.

Main Methods:

• Utilized MIN6-K8 beta cells and CRISPR-Cas9-engineered mouse islets with VGF lacking NERP-4 (VGF^△NERP-4).
• Assessed insulin secretion, beta cell maintenance, and insulin granule formation.
• Administered NERP-4 to VGF^△NERP-4 beta cells to evaluate rescue effects.
• Analyzed NERP-4 levels in islets from patients with type 2 diabetes.

Main Results:

• VGF^△NERP-4 cells demonstrated reduced insulin secretion and impaired beta cell maintenance.
• Defective insulin granule formation was observed in VGF^△NERP-4 cells, characterized by insulin accumulation in the trans-Golgi network.
• NERP-4 administration partially restored beta cell maintenance but did not rescue insulin granule formation.
• NERP-4 levels were found to be decreased in the islets of patients with type 2 diabetes mellitus.

Conclusions:

• NERP-4 is crucial for beta cell viability and plays a significant role in insulin secretion.
• The NERP-4 region within VGF is essential for proper insulin granule formation (granulogenesis).
• Reduced NERP-4 levels in type 2 diabetes suggest its involvement in the pathophysiology of the disease.